Advanced search
Publication Cover
Australian and New Zealand Journal of Psychiatry Volume 37, 2003 - Issue 1
Journal homepage
55
Views
15
CrossRef citations to date
0
Altmetric
Original

Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study

Vaughan J. Carr Centre for Mental Health Studies, University of Newcastle, Callaghan, NSW, 2308, Australia
,
Amanda L. Neil Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, Australia
,
Sean A. Halpin Psychological Assistance Service, Hunter Mental Health and the Centre for Mental Health Studies, Newcastle, Australia
,
Scott Holmes Graduate School, University of Newcastle, Newcastle, Australia
&
Terry J. Lewin Hunter Mental Health and the Centre for Mental Health Studies, Newcastle, Australia
Pages 31-40 | Received 02 Nov 2001, Accepted 16 May 2002, Published online: 07 Aug 2009

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (15)

Ben F.M. Wijnen, Frederick W. Thielen, Steef Konings, Talitha Feenstra, Mark Van Der Gaag, Wim Veling, Lieuwe De Haan, Helga Ising, Mickaël Hiligsmann, Silvia M.A.A. Evers, Filip Smit & Joran Lokkerbol. (2020) Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis. Expert Review of Pharmacoeconomics & Outcomes Research 20:3, pages 269-279.
Read now
Amanda L Neil & Vaughan J Carr. (2017) Global economic burden of schizophrenia: response to authors’ reply. Neuropsychiatric Disease and Treatment 13, pages 457-458.
Read now
Huey Yi Chong, Siew Li Teoh, David Bin-Chia Wu, Surachai Kotirum, Chiun-Fang Chiou & Nathorn Chaiyakunapruk. (2016) Global economic burden of schizophrenia: a systematic review. Neuropsychiatric Disease and Treatment 12, pages 357-373.
Read now
Amanda L Neil & Vaughan J Carr. (2016) Global economic burden of schizophrenia: letter in response. Neuropsychiatric Disease and Treatment 12, pages 3069-3072.
Read now
Helen J. Stain, Scott Clark, Maryanne O'Donnell & Ulrich Schall. (2010) Young rural people at risk for schizophrenia: Time for mental health services to translate research evidence into best practice of care. Australian and New Zealand Journal of Psychiatry 44:10, pages 872-882.
Read now
Sally Plever, Brett Emmerson, Benjamin Chapple, Craig Kennedy & Aaron Groves. (2010) The Queensland Mental Health Clinical Collaborative and the management of schizophrenia. Australasian Psychiatry 18:2, pages 106-114.
Read now
Paul Fitzgerald, Anthony de Castella, Dinesh Arya, W. Robert Simons, Andrew Eggleston, Sharon Meere & Jayashari Kulkarni. (2009) The cost of relapse in schizophrenia and schizoaffective disorder. Australasian Psychiatry 17:4, pages 265-272.
Read now
Paul B. Fitzgerald, William Montgomery, Anthony R. de Castella, Kate M. Filia, Sacha L. Filia, Laura Christova, Dan Jackson & Jayashri Kulkarni. (2007) Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics. Australian and New Zealand Journal of Psychiatry 41:10, pages 819-829.
Read now
Ruth Williams & Darrel Doessel. (2006) A report on economic studies of Australian mental health issues. Australasian Psychiatry 14:2, pages 141-145.
Read now
Vaughan J. Carr, Terry J. Lewin & Amanda L. Neil. (2006) What is the value of treating schizophrenia?. Australian and New Zealand Journal of Psychiatry 40:11-12, pages 963-971.
Read now
Vera Morgan, Ailsa Korten & Assen Jablensky. (2006) Modifiable risk factors for hospitalization among people with psychosis: evidence from the National Study of Low Prevalence (Psychotic) Disorders. Australian and New Zealand Journal of Psychiatry 40:8, pages 683-690.
Read now
R. Goeree, F. Farahati, N. Burke, G. Blackhouse, D. O’Reilly, J. Pyne & J.‐E. Tarride. (2005) The economic burden of schizophrenia in Canada in 2004. Current Medical Research and Opinion 21:12, pages 2017-2028.
Read now
Reinhold Kilian & Thomas Becker. (2005) Impact of antipsychotic medication on the cost of schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research 5:1, pages 39-57.
Read now
Anne Magnus, Vaughan Carr, Cathrine Mihalopoulos, Rob Carter & Theo Vos. (2005) Assessing cost-effectiveness of drug interventions for schizophrenia. Australian and New Zealand Journal of Psychiatry 39:1-2, pages 44-54.
Read now
Amanda L. Neil, Terry J. Lewin & Vaughan J. Carr. (2003) Allocation of resources and psychosis. Australian and New Zealand Journal of Psychiatry 37:1, pages 15-23.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.